The PTEN tumour suppressor is a lipid and protein phosphatase that inhibits phosphoinositide 3-kinase (PI3K)-dependent signalling by dephosphorylating phosphatidylinositol 3,4,5-trisphosphate (PtdInsP 3 ). Here, we discuss the concept of PTEN as an 'interfacial enzyme', which exists in a high activity state when bound transiently at membrane surfaces containing its substrate and other acidic lipids, such as PtdIns(4,5)P 2 and phosphatidylserine (PtdSer). This mechanism ensures that PTEN functions in a spatially restricted manner, and may explain its involvement in forming the gradients of PtdInsP 3 , which are necessary for generating and/or sustaining cell polarity during motility, in developing neurons and in epithelial tissues. Coordinating PTEN activity with alternative mechanisms of PtdInsP 3 metabolism, by the tightly regulated SHIP 5-phoshatases, synthesizing the independent second messenger PtdIns(3,4)P 2 , may also be important for cellular polarization in some cell types. Superimposed on this interfacial mechanism are additional post-translational regulatory processes, which generally act to reduce PTEN activity. Oxidation of the active site cysteine residue by reactive oxygen species and phosphorylation of serine/threonine residues at sites in the C-terminus of the protein inhibit PTEN. These phosphorylation sites also appear to play a role in regulating both stability and localization of PTEN, as does ubiquitination of PTEN. Because genetic studies in mice show that the level of expression of PTEN in an organism profoundly influences tumour susceptibility, factors that regulate PTEN, localization, activity and turnover should be important in understanding its biological functions as a tumour suppressor.
Introduction
The tumour suppressor PTEN is a dual-specificity phosphatase, which antagonizes phosphoinositide 3-kinase (PI3K)-dependent signalling by hydrolysing phosphatidylinositol 3,4,5-trisphosphate (PtdInsP 3 ) ( Figure 1 ) and may also dephosphorylate specific protein substrates. In many cellular assays and in vivo, PTEN acts to suppress cell growth, proliferation and survival and, in a more cell specific manner, plays a role in the establishment of polarity and inhibits the migration of several mammalian cell types (Liliental et al., 2000; Suzuki et al., 2003 Suzuki et al., , 2008 Lacalle et al., 2004; Leslie and Downes, 2004) . Many of the effects of PTEN on cell growth, proliferation and survival are believed to be mediated through its inhibition of the PtdInsP 3 -dependent protein kinase Akt (Manning and Cantley, 2007) . However, the effects of PTEN on cell polarity and migration seem to be mediated more through other PtdInsP 3 -dependent pathways, in particular, the small GTPases of the Rac, Cdc42 and Arf families, and may involve lipid phosphatase-independent actions of PTEN (Liliental et al., 2000; Raftopoulou et al., 2004; Leslie et al., 2007; Dey et al., 2008) . The differential effects of these pathways also highlight the distinction between the effects of PI3K/PTEN that depend simply on cellular PtdInsP 3 levels (signal amplitude) and those that depend critically on the subcellular targeting of activity contributing to PtdInsP 3 gradients (signal localization) (Leslie et al., 2001; von Stein et al., 2005; Pinal et al., 2006) .
Regulation of PTEN activity and/or expression serves not only to modulate the temporal and spatial distribution of PtdInsP 3 , but also its availability for an alternative route of metabolism to PtdIns(3,4)P 2 by 5-phosphatases. The ability to switch the output of PI3K signalling between PtdInsP 3 and PtdIns(3,4)P 2 is also likely to have important implications in cell biology and pathological conditions such as cancer.
Targeting PTEN activity to acidic membranes rich in PtdIns(4,5)P 2 PTEN is an interfacially activated enzyme To access its lipid substrate, PtdInsP 3 , the cytosolic pool of PTEN must associate at least transiently with membrane surfaces. Studies comparing rates of metabolism of PtdInsP 3 in synthetic lipid vesicles versus inositol 1,3,4,5-tetrakisphosphate (the soluble headgroup of PtdInsP 3 ) showed that this interfacial interaction was not passive, but could account for up to a 10 000-fold difference in K cat values for these two substrates (McConnachie et al., 2003) . This led to our proposal of a model in which PTEN can exist in two active states, one favouring metabolism of soluble substrates and the other, the interfacially activated state, necessary for efficient metabolism of PtdInsP 3 (Downes et al., 2007b) (Figure 2 ). The interfacially active state was also found to favour PtdInsP 3 as the substrate, explaining why, despite being able to metabolize PtdIns(3,4)P 2 , PtdIns(3,5)P 2 and PtdIns3P under some in vitro conditions, PTEN appears to be highly specific for PtdInsP 3 in the cellular environment. Also supporting this specificity, other enzymes are required to metabolize cellular PtdIns3P and PtdIns(3,5)P 2 (myotubularins) or PtdIns(3,4)P 2 (inositol polyphosphate 4-phosphatases) efficiently.
Regulation of PTEN by PtdIns(4,5)P 2 and other acidic lipids The scale of the interfacial activation when PTEN associates with a membrane or vesicular substrate depends largely on the composition of the membrane and particularly its surface characteristics. These include the overall surface charge, largely determined both by its phosphatidylserine (PtdSer) content and, specifically, on the presence of PtdIns(4,5)P 2 , both of which appear to mediate electrostatic interactions with the basic membrane-binding surfaces of PTEN. Data supporting this come from both direct analysis of PTEN's lipid surface binding Das et al., 2003; Vazquez et al., 2006; Redfern et al., 2008) and analysis of activity against substrates in acidic membranes or vesicles (Campbell et al., 2003; McConnachie et al., 2003; Iijima et al., 2004; Walker et al., 2004) .
Initial experiments addressing the effects of PtdIns(4,5)P 2 and other acidic lipids within target membranes or vesicles tended to focus on the role of these basic lipids in recruiting PTEN onto these surfaces, increasing access to the substrate lipid (Das et al., 2003; Walker et al., 2004) . However, a role for acidic lipids in the direct regulation of PTEN activity was also proposed (Campbell et al., 2003; Iijima et al., 2004) . This latter proposal has now been strongly supported by data from the groups of Alonso Ross and Arne Gericke, indicating that acidic lipids, and PtdIns(4,5)P 2 in particular, actually cause a conformational change within the enzyme and allosteric activation (Redfern et al., 2008) . Infrared spectroscopy experiments not only indicate that the N-terminus of PTEN binds specifically to PtdIns(4,5)P 2 inducing an increase in the PTEN a-helical content, but also that simultaneous binding to PtdSer can also cause conformational alterations in PTEN (Redfern et al., 2008) . This suggests that both recruitment and activity effects enhance PTEN activity toward PtdInsP 3 substrate that is present in membranes enriched with PtdIns(4,5)P 2 and Figure 1 A model of phosphoinositide 3-kinase (PI3K)-dependent signalling is shown, detailing the synthesis of PtdIns(3,4,5)P 3 from PtdIns(4,5)P 2 via phosphorylation at the third position of the inositol ring by PI3K. PTEN catalyses the conversion of PtdInsP 3 back to PtdIns(4,5)P 2 , whereas 5-phosphatases, such as the SHIP proteins, convert PtdInsP 3 to PtdIns(3,4)P 2 . These two PI3K-dependent signals, PtdInsP 3 and PtdIns(3,4)P 2 , share several downstream binding targets, including Akt. However, each of them also have specific targets, such as the Arf GEFs GRP1 and ARNO, which bind selectively to PtdInsP 3 , and the TAPP and lamellipodin proteins, which bind selectively to PtdIns(3,4)P 2 . Still further proteins are known to bind to these lipid targets, but their relative specificities have not been analysed thoroughly. GEF, guanine-nucleotide exchange factor; TAPP, tandem pleckstrin-homology domain-containing protein.
other acidic lipids, such as PtdSer. A potential functional consequence of this is suggested by experiments that identified pools of PtdInsP 3 in the nuclear matrix and on the endoplasmic reticulum and other endomembrane compartments in PTEN-null cells. Expression of PTEN in these experiments reduced the PtdInsP 3 pool at the plasma membrane, but had no effect on the nuclear matrix or endoplasmic reticulum pools, suggesting that cytosolic PTEN is unable to access substrate in the less-acidic endoplasmic reticular compartment (Lindsay et al., 2006) . Further implication that PTEN activity is enhanced toward PtdInsP 3 in regions of the plasma membrane that are relatively rich in PtdIns(4,5)P 2 , especially in polarized cells, is discussed below.
Do changes in membrane charge represent a mechanism to rapidly regulate PTEN? PTEN recruitment onto the plasma membrane is believed to rely on electrostatic interactions with anionic lipids within this membrane, and probably additional protein-protein interactions Vazquez et al., 2006) . The acidic charged character of this membrane is believed to be contributed by several anionic lipids, including PtdSer, PtdIns(4,5)P 2 , PtdIns and phosphatidic acid (Yeung and Grinstein, 2007; Yeung et al., 2008) . As such it was assumed by many researchers that this characteristic of the membrane would remain relatively constant within a given cell. However, recent data from Sergio Grinstein's lab have challenged this assumption, by developing well-validated 'charge probes' that display a localization on the plasma membrane that is dependent on electrostatic interactions between basic residues within the probe and anionic lipids, including PtdIns(4,5)P 2 and PtdSer (Yeung et al., 2006) . These and other experiments have shown that not only do these probes move off the plasma membrane in response to depletion of membrane PtdIns(4,5)P 2 and PtdSer (Heo et al., 2006; Yeung et al., 2006) , but, in macrophages, they also move away from the membrane during phagocytosis, selectively in the area of the phagocytic cup, and in contrast to fluorescent probes that localize to the plasma membrane through hydrophobic interactions (Yeung et al., 2006 ). An interesting aspect of the work of Heo et al. is that PtdInsP 3 also appeared to be playing a part in controlling the electrostatic membrane recruitment of proteins containing polybasic regions, although, because PtdInsP 3 is present at such low concentrations in membranes, this seems to suggest either a surprising specificity in the interaction or an indirect mechanism (Yeung et al., 2006) . Nevertheless, these data suggest an unexpected possible autoregulatory feedback mechanism of PTEN regulation (Yeung et al., 2006) .
Taken together, these studies suggest that the simple surface charge characteristic that appears to hold both these basic charge probes and PTEN onto the plasma membrane can be modified by signalling, probably through phospholipase (PLC). This implicates both PIP 2 and PtdSer in the recruitment of PTEN onto membranes and also in independent allosteric activation of the phosphatase. These studies also agree very well with recent results showing that in the social amoeba Dictyostelium discoideum PLC appears to act upstream of PTEN, regulating its membrane recruitment and activity Korthol et al., 2007) . It will be interesting to see whether the regulation of PTEN by PLC will prove to be a conserved and widely applicable regulatory mechanism.
Metabolism of PtdInsP 3 by the SHIP 5-phosphatases
In addition to the 3-phosphatase action of PTEN, cellular PtdInsP 3 concentrations are also regulated by the sequential activity of 5-and 4-phosphatases producing PtdIns(3,4)P 2 and PtdIns3P, respectively. As these molecules can act as distinct signals, the alternative, initial routes of PtdInsP 3 removal by PTEN or 5-phosphatases are not redundant but likely serve separate roles that confer flexibility to PI3K signalling. Thus, the capacity of PTEN to limit PtdInsP 3 concentrations may restrict metabolism by 5-phosphatases and thereby modulate both the magnitude and nature of the signalling output from PI3K (Figure 1) .
Regulation of the SHIP 5-phosphatases
Consistent with the view that the consequences of PtdInsP 3 3-and 5-phosphatase activities are functionally distinct, none of the members of the family of inositol Figure 2 A hypothetical model of the interfacial activation of PTEN at a membrane surface rich in PtdIns(4,5)P 2 is shown. PTEN is proposed to undergo a conformational change on interaction with PtdIns(4,5)P 2 and other membrane lipids, allowing it to take up a conformation with high activity against its PtdInsP 3 substrate. In solution, the relatively elevated activity of phosphorylated PTEN against inositol phosphates suggests that the C-terminal tail of PTEN may inhibit membrane interaction, while allowing access to soluble substrates, but also that a less active conformation may exist.
polyphosphate/phosphoinositide 5-phosphatases is known to function as a tumour suppressor despite the evidence that, in contrast to the unique role of PTEN, several are involved in PtdInsP 3 metabolism. Although others, including the proline rich inositol polyphosphate 5-phosphatase (Mochizuki and Takenawa, 1999) and the skeletal muscle inositol polyphosphate 5-phosphatase (Ijuin et al., 2000) , may also be important, the best characterized of these enzymes are the Src homology 2 (SH2) domain-containing inositol polyphosphate 5-phosphatases 1 and 2 (SHIP and SHIP2) (Krystal et al., 1999; Rohrschneider et al., 2000; Backers et al., 2003; Dyson et al., 2005; Harris et al., 2008) . SHIP is restricted primarily to cells of haematopoietic origin, whereas SHIP2 is much more widely distributed, a feature that probably accounts for the distinct biological consequences resulting from the separate loss of each enzyme (Helgason et al., 1998; Sleeman et al., 2005) , with the deletion of SHIP2 having particular implications for insulin signalling (Sleeman et al., 2005; Lazar and Saltiel, 2006) . Nevertheless, SHIP and SHIP2 share a similar, although not identical, multi-domain structure suggesting that these enzymes may be subject to complex regulation and/or may fulfil functions additional to, but likely integrated with, their PtdInsP 3 5-phosphatase activity. Key features of these enzymes, which confer the capacity for recruitment to multiprotein complexes, include an N-terminal SH2 domain and, C-terminal to the common 5-phosphatase domain, a proline rich region, which incorporates a double or single NPXY motif in SHIP and SHIP2, respectively (Rohrschneider et al., 2000; Backers et al., 2003; Dyson et al., 2005) . Consequently, each of these PtdInsP 3 5-phosphatases binds numerous protein partners through either SH3 domain-directed or reversible tyrosine phosphorylation-mediated interactions.
However, as neither protein binding nor tyrosine phosphorylation has been shown to increase the specific 5-phosphatase activity of SHIP or SHIP2 (Giuriato et al., 1997 (Giuriato et al., , 2002 Taylor et al., 2000; Blero et al., 2001) , the predominant effect of these modifications on PtdInsP 3 hydrolysis has been considered to reflect their associated re-localization from the cytosol to the vicinity of their lipid substrate (Rohrschneider et al., 2000; Backers et al., 2003) . Contrary to this view, two recent studies suggest that the specific activity of both 5-phosphatases is also subject to acute and dramatic regulation. The first shows that the activity of SHIP is increased substantially by the allosteric binding of PtdIns(3,4)P 2 to a putative C2-domain C-terminal to the 5-phosphatase domain, an effect that can be reproduced by exogenously applied small molecules (Ong et al., 2007) . The second demonstrates that, in contrast to previous reports, the specific activity of SHIP2 is markedly increased by the direct, PI3K-independent tyrosine phosphorylation of this protein (Batty et al., 2007) . Although important details of these mechanisms and their mutual exclusivity remain to be established, both studies indicate that, in apparent contrast to PTEN, PtdInsP 3 5-phosphatase activity can be acutely increased over a wide dynamic range such that this achieves full capacity only following stimulation. Furthermore, the ability to regulate 5-phosphatase activity independent of PI3K allows the balance of signalling output of the latter enzyme to be switched between PtdInsP 3 and PtdIns(3,4)P 2 .
What are the functions of PtdIns(3,4)P 2 ? Specific signalling functions have yet to be assigned to PtdIns(3,4)P 2 , but are clearly implied by the several proteins, including the TAPP (tandem pleckstrinhomology domain-containing protein) (Dowler et al., 2000) and lamellipodin (Krause et al., 2004) , which bind to this lipid with high selectivity, and others, such as DAPP1 (dual adaptor of phosphotyrosine and 3-phosphoinositides 1) (Dowler et al., 1999) and protein kinase B (Thomas et al., 2002) , which preferentially bind both PtdIns(3,4)P 2 and PtdInsP 3 . The degradation of PtdIns(3,4)P 2 is mediated by the types I and II inositol polyphosphate 4-phosphatases (Norris et al., 1995 (Norris et al., , 1997 Majerus et al., 1999) , and the functional significance of this activity is again implied both by the ability of the type I enzyme to regulate cell growth downstream of the GATA transcription factor (Vyas et al., 2000) and by the neuronal loss characteristic of Weeble mice that lack this protein (Nystuen et al., 2001) and express elevated cellular concentrations of PtdIns(3,4)P 2 (Shin et al., 2005) . Both the type I and II enzymes are expressed as a and b splice variants which lack and contain a hydrophobic C-terminal tail, respectively. Like PTEN, the 4-phosphatases have the essential CXXXXXR catalytic phosphatase motif characteristic of the protein tyrosine phosphatase family of enzymes and, thus, may be similarly susceptible to inhibition by reactive oxygen species (ROS) (Downes et al., 2007a) . Thus, it is tempting to speculate that ROS produced endogenously downstream of PI3K-coupled receptors might inhibit both PTEN and 4-phosphatases, thereby promoting the accumulation of PtdIns(3,4)P 2 in particular. Indeed, exogenously applied peroxide and other protein tyrosine phosphatase inhibitors, such as vanadate analogues, dramatically and selectively increase cellular PtdIns(3,4)P 2 above the normally very low resting concentrations, consistent with an important metabolic role for the potentially redox-sensitive 4-phosphatase enzymes (Van der Kaay et al., 1999; Batty et al., 2007) . The lipid product of 4-phosphatase activity is PtdIns3P whose role in vesicle trafficking is well established (Simonsen et al., 2001) , and although it is not certain that the pools of this lipid produced by PtdInsP 3 dephosphorylation are functionally equivalent to those generated by class II or class III PI3Ks, the formation of PtdIns3P represents a further distinguishing feature of metabolism by this route.
Thus, although PtdInsP 3 is metabolized by PTEN and by 5-phosphatases, these two pathways likely fulfil distinct, although integrated, roles in PI3K signalling. Although PTEN is believed to be constitutively active in resting and stimulated cells, 5-phosphatases, such as SHIP and SHIP2, are likely to be acutely regulated so that their low resting activity is dramatically increased on stimulation by both their re-localization to sites of PtdInsP 3 synthesis, mediated by their capacity for targeted protein interaction, and by marked increases in their specific activity. Ultimately, therefore, the relative capacities of the two routes responding to differing prevailing regulatory influences can be expected to allow variability not only in the magnitude but also in the spectrum of 3-phosphoinositide signals generated by PI3K, which, in conjunction with additional temporal and spatial constraints on these, enhances the flexibility of PI3K-dependent signalling.
Regulation by phosphorylation
Serine/threonine phosphorylation of PTEN The C-terminal, apparently unstructured tail of PTEN contains several sites of serine and threonine phosphorylation ( Figure 3 ). These form two separable groups comprising a close cluster of four residues, Ser380, Thr382, Thr383 and Ser385, and a pair of residues slightly more N-terminal, Thr366 and Ser370. The 380-385 cluster sites all appear to be phosphorylated by CK2, based on evidence that these sites are excellent substrates for CK2 in vitro, their phosphorylation is sensitive to relatively selective CK2 inhibitors in cells and the kinase and PTEN appear to interact directly in pull-down experiments (Torres and Pulido, 2001; Miller et al., 2002; Arevalo and Rodriguez-Tebar, 2006) . In addition, the phosphorylation of these sites by a cell extract in vitro is also sensitive to selective CK2 inhibitors, when detected using phosphospecific antibodies against P-S380, P-S385 or the combined 380/2/3 sites (Nick Leslie and James Murray, unpublished data). Both analysis of the effects of phospho-mimicking mutations and estimates of stoichiometry based on data comparing cell lysates with in vitro phosphorylated protein imply that, at least in several cell lines, the stoichiometry of phosphorylation at these sites is quite high, possibly greater than 50% (Vazquez et al., 2000; Maccario et al., 2007) . However, the detection of significant stimulation of phosphorylation at these sites, especially seen in neuronal tissues, would argue that the maintained basal phosphorylation levels must be much lower in some cell types Arevalo and Rodriguez-Tebar, 2006; Ning et al., 2006) . It should be noted that although there have been relatively few additional reports of the stoichiometry of phosphorylation of these sites being rapidly modulated, for example, during signalling, most of this work has been performed in primary cells and in vivo (Choi et al., 2004; Okamura et al., 2006; Rafiq et al., 2006; Hoshino et al., 2007; Song et al., 2007) .
Important early studies of these PTEN phosphorylation sites led to the proposal of a model in which phosphorylated PTEN adopts a 'closed' conformation, which is more stable, less able to engage in PDZ domain-dependent interactions and generally less active in cellular assays (Vazquez et al., 2001) . Subsequent data have supported this model, adding details regarding the effects of phosphorylation to suppress membrane association (Das et al., 2003; Vazquez et al., 2006; Odriozola et al., 2007) , nuclear localization (Gil et al., 2006) , PDZ binding (Tolkacheva et al., 2001; Valiente et al., 2005) , ubiquitination and degradation (Tolkacheva et al., 2001; Torres and Pulido, 2001; Wu et al., 2003) , and phosphatase activity (Miller et al., 2002; Ning et al., 2006; Odriozola et al., 2007) . Although this model has stood the test of much further work, much of this supportive data derive from the use of mutant proteins, in which phosphorylation sites have been replaced by unphosphorylatable alanine residues. One such commonly used mutant (PTEN 380A, 382A, 383A) has now been shown to have much greater catalytic activity in vitro than an unphosphorylated bacterially expressed wild-type protein (Ning et al., 2006; Odriozola et al., 2007) , strongly suggesting that in cellular experiments, this mutation will cause an activation far greater than that caused by simply blocking phosphorylation. Although this does not call into question the current models for PTEN regulation, it does suggest that better experimental approaches are required to provide clearer insight into this issue. Also, in the unstructured C-terminal tail, Ser370 and Thr366 appear to be phosphorylated by CK2 and GSK3, respectively; this conclusion being similarly based on data from in vitro phosphorylation and inhibitor analysis (Al-Khouri et al., 2005; Maccario et al., 2007) . Having been identified more recently, the function of phosphorylation on these sites is rather unclear, although there is evidence for the suppression of activity (Al-Khouri et al., 2005) , the cell-type-specific reduction in PTEN protein stability (Maccario et al., 2007) and the mediation of a novel phosphataseindependent tumour suppressor function (Okumura et al., 2005) . This last study also identified a novel interaction between PTEN and the FHA domaincontaining protein MSP58, mediated by a phosphospecific interaction between the FHA domain and phosphothreonine 366 (Okumura et al., 2005) . Despite the strong data for CK2 and GSK3 as the dominant kinases responsible for PTEN C-terminal phosphorylation in several cell types, other kinases are able to phosphorylate PTEN efficiently in vitro and may contribute to regulating specific PTEN functions.
Tyrosine phosphorylation of PTEN
Now there is strong evidence that PTEN can be phosphorylated on tyrosine residues. Initial studies indicating PTEN tyrosine phosphorylation (Koul et al., 2002; Lu et al., 2003) have been backed up by data from a global analysis of tyrosine phosphorylation in lung tumours and cell lines, which indicated that tyrosine phosphorylation of PTEN was present in most examples of a definable rare subset of these tumours, but not detected in the great majority (Rikova et al., 2007; Guo et al., 2008) . This suggests that PTEN tyrosine phosphorylation may occur only in certain cell types and circumstances, or that only an extremely small proportion of the cellular PTEN normally becomes tyrosine phosphorylated. Although the sites of tyrosine phosphorylation have not been identified with great confidence, mass spectrometry data indicate a tyrosinephosphorylated peptide within the phosphatase domain very close to its junction with the C2 domains (Guo et al., 2008) . Although the functional consequences of tyrosine phosphorylation are currently unclear in molecular terms, recent reports have associated PTEN tyrosine phosphorylation with regulation by RhoA and ROCK Sanchez et al., 2005; Papakonstanti et al., 2007) .
Regulation of PTEN's stability
The regulation of PTEN's stability has been extensively studied, but the detailed mechanisms implicated and the pathways controlling stability are still poorly understood. As mentioned above, the phosphorylation state of its C-terminal tail and interaction with specific partners via this C-terminal domain are the two main mechanisms implicated in regulating PTEN's stability. As discussed, the protein kinase CK2 phosphorylates a cluster of serine and threonine residues located near the C-terminus of PTEN. Dephosphorylation or alanine mutation of these sites provokes a decrease in PTEN's stability in comparison with wild-type PTEN (Vazquez et al., 2000; Torres and Pulido, 2001) . Moreover, recently our data showed that PTEN is phosphorylated on threonine 366 and serine 370 by GSK3 and CK2, respectively, and that blocking phosphorylation on threonine 366 by either alanine mutation or GSK3 inhibition in glioblastoma cell lines, in this case, led to a stabilization of the PTEN protein (Maccario et al., 2007) . So, PTEN's stability can be controlled by the phosphorylation state of multiple sites along its C-terminal tail, apparently acting in opposition.
On the other hand, although the phosphorylation state of PTEN has a big impact on its stability, PTEN's interaction with specific partners also regulates its stability. Indeed, PTEN associates with a variety of scaffolding and/or regulatory molecules via its C-terminal tail Okahara et al., 2004; Takahashi et al., 2006) . Notably, the PTEN PDZ-binding domain binds to several proteins, including MAGI-2 and MAST205. These interactions appear to enhance PTEN's stability, as interference with either these binding partners or PTEN's ability to bind them greatly reduces PTEN's stability (Wu et al., 2000; Subauste et al., 2005; Valiente et al., 2005) .
The mechanisms associating C-terminal phosphorylation and PDZ-mediated protein-protein interactions to stability are far from clear. A protein named PICT-1 (protein interacting with the C-tail-1) has been shown to interact with the C terminus of PTEN, promoting both phosphorylation and stability of PTEN (Okahara et al., 2004) . It has also been shown that during apoptosis, the PTEN protein is cleaved by caspase 3 at several target sites and that this cleavage is also suppressed by CK2-mediated PTEN phosphorylation (Torres et al., 2003) . However, most data currently support a dominant role for ubiquitin regulated proteasomal degradation in controlling PTEN's stability. PTEN has two canonical PEST motifs, a signature in many short-lived proteins degraded by the ubiquitin-proteasome pathway. Moreover, treatment of many cell types with proteasome inhibitors enhances the levels of PTEN protein (Tolkacheva et al., 2001; Torres and Pulido, 2001) , and recently an in vitro ubiquitination assay using cell extracts or the ligase E3 Nedd4.1, along with cellular ubiquitination experiments, has shown that PTEN is both mono-and polyubiquitinated Wang et al., 2007) . Significantly, this work also indicated that PTEN monoubiquitination controlled the nuclear localization of PTEN, alongside the effects of polyubiquitination on PTEN's stability. In addition, Wang et al. (2007) , using overexpression or RNAi approaches in 293T cells, implicated Nedd4.1 as the dominant ubiquitin ligase E3 for PTEN in their experiments. Interaction between PTEN and Nedd4.1 has been observed in several cell lines, and a novel mutual regulation between PTEN and Nedd4.1 is suggested by the studies of Ahn et al. (2008) . Given the emerging complexity and significance of ubiquitin in regulating protein stability and other signalling systems, it seems likely that much remains to be discovered regarding how PTEN ubiquitination is controlled and regarding the roles of ubiquitin and possibly related molecules in PTEN regulation.
PTEN oxidation activates PI3K-dependent signalling
PTEN is a member of the diverse protein tyrosine phosphatase superfamily, which share a catalytic mechanism requiring a reduced active site cysteine nucleophile, the reactivity of which makes it sensitive to oxidation. In PTEN, it has been shown that oxidation with H 2 O 2 in vitro, or treatment of cells with H 2 O 2 , can lead to the formation of a disulphide bond between the active site Cys124 and another very closely located cysteine, Cys71 (Figure 3) . Subsequent work showed that the regulation of downstream PI3K-dependent Akt/PKB activation by H 2 O 2 oxidative stress is by PTEN oxidation, and that this oxidative inhibition mechanism appears to contribute to the activation of Akt/PKB in artificially LPS/PMA-stimulated macrophages, generating high levels of endogenous ROS (Leslie et al., 2003) . Oxidation of PTEN has now been shown in cells stimulated with a range of peptide growth factors, in which the stimulated generation of endogenous ROS is at greatly lower levels than that found in macrophages, also accompanied by an oxidant-dependent activation of downstream Akt signalling (Kwon et al., 2004; Seo et al., 2005) . In these studies, PTEN oxidation was identified in insulin-stimulated neuroblastoma cells or HEK293 cells, in EGF-stimulated HeLa cells and in PDGF-stimulated NIH3T3 fibroblasts, using band-shift assays in addition to biotinylation and alkylation protection methods (Kwon et al., 2004; Seo et al., 2005) . Although a clear picture of the molecular mechanisms and oxidative changes that occur in PTEN during redox signalling is yet to emerge, further possibilities for PTEN redox regulation were raised by studies demonstrating PTEN inactivation through nitrosylation and in response to cellular arachidonic acid treatment (Yu et al., 2005; Covey et al., 2007) .
Currently, it is clear that redox signalling plays a critical role in mediating the cellular responses to many stimuli, including many growth factors, cytokines and hormones (Rhee et al., 2005) , and may contribute to several regulated steps in the PI3K signalling pathway, including PTEN (Leslie, 2006) . However, the experimental challenges of studying redox signalling have resulted in only a few studies in which these pathways have been elucidated in detail in more physiological settings. Perhaps the best example proposed for the physiological significance of PTEN oxidation is currently in muscle. In cardiac muscle, ischaemia and reperfusion led to both the degradation and oxidation of PTEN associated with the activation of Akt (Cai and Semenza, 2005) . Further studies implicating PTEN oxidation in both cardiac and skeletal muscle suggest that the thioredoxin-interacting protein Txnip is required for the maintenance of thioredoxin NADPH levels, and efficient PTEN reduction, as muscle lacking Txnip displays elevated Akt activation and a redoxdependent loss of PTEN antigenicity (Hui et al., 2008) .
PTEN localization and activity in polarized cells

Cellular localization of PTEN
The first descriptions of PTEN localization within cells, either using fluorescently tagged protein or immunofluorescence, were obtained from a variety of cultured cell lines, in which PTEN appears diffusely cytosolic, with a somewhat variable nuclear component (Li and Sun, 1997; Leslie and Downes, 2004) . It is clear that PTEN is enriched in the nucleus of some cell types (Gimm et al., 2000; Perren et al., 2000) . However, our understanding of the mechanisms regulating this nuclear localization Gil et al., 2006; Trotman et al., 2007) and, in particular, its functional consequences is currently at a relatively early stage and has been described by others (Baker, 2007) , and so will not be discussed further here.
Single-molecule studies using total internal reflection fluorescence microscopy in Dictyostelium and HEK293 cells have shown that PTEN associates stably, but transiently, with the plasma membrane, with PTEN-YFP having a residence time 'half-life' on the plasma membrane of a cultured HEK293 cell of around 150 ms (Vazquez et al., 2006) . This work suggests that PTEN is probably abundant on most cell membranes relative to the cytosol, and possibly concentrated on some specific membrane regions and domains, but this localization is often outside the detection limits of standard fluorescence microscopy. Nevertheless, recent analyses in vivo, in primary cells or using cultured cells retaining significant cellular architecture and polarity, have begun to suggest that PTEN is enriched at specialized sites, in particular, at the apical domains of polarized epithelial cells (Li et al., 2003; von Stein et al., 2005; Chadborn et al., 2006; Pinal et al., 2006; Leslie et al., 2007; MartinBelmonte et al., 2007) (Figure 4 ). This epithelial polarization of PTEN was shown originally in Drosophila (von Stein et al., 2005; Pinal et al., 2006) , and later in the chick embryo epiblast epithelium and in polarized MDCK kidney and T84 colon cells in 3D culture Martin-Belmonte et al., 2007) . In Drosophila, PDZ-dependent interaction with Bazooka/dPAR3 in the zonula adherens was implicated in the apical PTEN localization, and in these experiments, apical localization was limited to the Drosophila PTEN2 isoform, which has a C-terminal PDZ-binding sequence. Biochemical evidence from mammalian epithelial cells also positions PTEN in apical adherens junction complexes, targeted through its PDZ-binding motif and the Par3 and MAGI proteins (Kotelevets et al., 2005; Subauste et al., 2005; Wu et al., 2007) .
It is perhaps worth mentioning that although some of these localization studies have used fluorescently tagged PTEN proteins, the involvement of both termini in targeting the protein (to anionic lipids through the N-terminus and PDZ domains through the C-terminus) means that, where possible, localization of the endogenous protein is clearly preferable. In this regard, only a few antibodies have been shown to be suitable for immunofluorescent analysis, with most consistent results probably being obtained using a well-validated monoclonal antibody named 6H2.1 (Perren et al., 1999; Pallares et al., 2005) . In addition, N-terminal tagging of PTEN can be problematic, and can lead to a loss of cellular function (Lacalle et al., 2004) .
PTEN and the regulation of cellular polarity
It has emerged over the past 5 or 6 years, that PTEN and PtdInsP 3 play conserved roles in the determination of cell polarity in very diverse cell types (Figure 4) . Data, obtained first from Dictyostelium cells (Parent et al., 1998; Meili et al., 1999; Funamoto et al., 2002; and later from neutrophils undergoing chemotaxis (Servant et al., 2000; Li et al., 2003) , show enrichment of PtdInsP 3 at the leading edge of these cells and localization of PTEN to the back, although the localization of PTEN in neutrophils is still controversial (Xu et al., 2003; Lacalle et al., 2004; Li et al., 2005) . This work has now been extended to show that Dictyostelium display a related but bipolar polarization during cytokinesis, with PTEN localizing to the furrow and PtdInsP 3 being enriched at the poles (Janetopoulos and Devreotes, 2006) . In polarizing neurons, PtdInsP 3 appears to be enriched at the growth cone, in particular, in the developing axon during neuronal polarization (Shi et al., 2003; Aoki et al., 2005) , with PTEN being excluded from this region until growth cone collapse (Chadborn et al., 2006) . Functionally, Dictyostelium cells lacking PTEN have defects in polarization and chemotaxis, and mutation of PTEN/ daf-18 in Caenorhabditis elegans or knockdown of PTEN expression in rat hippocampal neurons causes aberrant neuronal polarization (Funamoto et al., 2002; Jiang et al., 2005; Adler et al., 2006) . In contrast, several mammalian cell types, including B cells and fibroblasts, migrate faster when where identified, is shown in blue, and PtdInsP 3 in specific membranes is shown in red. PtdInsP 3 has been described at the leading edge of neutrophils, fibroblasts and Dictyostelium cells during chemotaxis; the basolateral membranes of breast and kidney epithelial cell lines; the axonal growth cones of polarizing neurons; and in extending neurites, at the immunological synapse during T-cell activation, with a weaker localization at the opposite pole of these lymphocytes; and finally at the two poles of Dictyostelium cells undergoing cytokinesis. Conversely, PTEN localizes to the back of Dictyostelium cells, and possibly neutrophils, during chemotaxis, to the apical membrane of several epithelial cell types, and to the furrow of Dictyostelium cells undergoing cytokinesis. Very similar distributions have been described for PtdIns(4,5)P 2 , being localized along with PTEN on the apical membranes of some epithelial cells and at the furrow of dividing Dictyostelium cells. We are not aware of data localizing PtdIns(4,5)P 2 during chemotaxis. It should be noted that although a PtdInsP 3 gradient and cell polarity are maintained for many hours during T-cell activation, it appears that PI3K/PTEN signalling is not required for efficient cell polarization and activation in this circumstance (Costello et al., 2002; Harriague and Bismuth, 2002) . Further details and references are in the main text. PIP 3 , phosphatidylinositol 3,4,5-trisphosphate. lacking PTEN, although cellular polarization has not been studied in great detail in these cases (Liliental et al., 2000; Suzuki et al., 2003) .
Most recently, the investigation of PTEN's role in regulating cell polarity in MDCK kidney epithelial cells has provided the most detailed evidence to date that PTEN is also important in epithelial cell polarization and plays a role in the regulation of phosphoinositide gradients defining apical and basolateral membrane domains within these cells (Martin-Belmonte et al., 2007) . This study showed that both PTEN and PtdIns(4,5)P 2 are enriched on the apical membrane of polarized MDCK cells, whereas PtdInsP 3 is enriched on the basolateral membrane, relative to the apical membrane. This study also presented data showing that Annexin 2 binds to cdc42, as well as to PtdIns(4,5)P 2 , and that PTEN, Annexin2 and cdc42 are all apically localized and required for correct polarization and lumen formation. These results build on earlier data from a mammary epithelial cell line, in which polarization in 3D culture was dependent on PI3K signalling and resulted in basolateral accumulation of PtdInsP 3 (Liu et al., 2004) . The recent study in MDCK cells also proposed that PTEN may act to generate PtdIns(4,5)P 2 from PtdInsP 3 in the apical domain, but as PtdInsP 3 is a minor lipid believed almost always to be generated from PtdIns(4,5)P 2 , which generally exists in at least a 100-fold excess, it seems unlikely that this proposal is correct. Further evidence for a role in regulating epithelial architecture comes from the effects of PTEN on cell migration events in the early chick embryo. Here, PTEN inhibits the epithelial to mesenchymal transition that epiblast cells undergo before they can migrate toward the embryo periphery, and this effect requires the C-terminal PDZ-binding motif and the protein phosphatase activity of PTEN .
PTEN function is very frequently lost during the development of epithelial-derived tumours, and many such tumours are believed to undergo a form of epithelial to mesenchymal transition before they metastasize. Together with the accumulating evidence that loss of cellular polarity and tissue architecture can be driving forces in tumour progression rather than its by-product (Wodarz and Nathke, 2007) , this indicates that these studies of PTEN in epithelial biology may be very relevant to the tumour suppressor functions of PTEN.
Although PI3K signalling is not absolutely required for cell polarity, and other parallel pathways regulating directed cell migration and polarization exist, data from diverse experimental models suggest that PI3K signalling may play a general role in many forms of cellular polarization (Arimura and Kaibuchi, 2007; Franca-Koh et al., 2007; Insall and Andrew, 2007) , linking in with other polarity systems, such as the Par3/Par6/aPKC complex. In particular, PI3K signalling appears to be one mechanism that would act as part of a positive feedback system, interacting in particular with Rho family GTPases and possibly actin, to establish a semistable polarized state Weiner, 2002; Charest and Firtel, 2006; Van Keymeulen et al., 2006) . Several other factors would also support the existence of distinct membrane domains containing relatively high and low ratios of PtdIns(4,5)P 2 to PtdInsP 3 , including the apparent roles for PtdInsP 3 in the activation of PLCg1 and the inhibition of RhoA (Bae et al., 1998; Falasca et al., 1998; Krugmann et al., 2004 Krugmann et al., , 2006 . In addition, the low K m of class I PI3K for PtdIns(4,5)P 2 means that generation of cellular PtdInsP 3 by PI3K is not affected by fluctuations in PtdIns(4,5)P 2 concentrations except under extreme conditions of PtdIns(4,5)P 2 depletion, and PLC-induced reductions in PtdInsP 3 accumulation appear to be mediated through inhibition of PI3K activation, rather than substrate limitation (Batty and Downes, 1996; Batty et al., 2004) .
PtdIns(3,4)P 2 and polarity? Evidence for the integrated synthesis and metabolism of PtdInsP 3 is emerging in several signalling systems Leslie, 2006) , and it seems likely that in the production of signal gradients, for example, during directed cell migration, the coordination of both PI3K activity and PtdInsP 3 metabolism is critical (Iglesias and Devreotes, 2008) . However, in some cases, it appears that the functionally significant route of metabolism is not via PTEN, but via the PtdInsP 3 5-phosphatase SHIP. In murine neutrophils, deletion of the Pten gene had little or no effect on chemotaxis or overt polarization in response to fMLP or C5a, whereas deletion of Ship1 caused a major failure in polarization and cell motility (Nishio et al., 2007) . Additional data supporting a significant role for PtdIns(3,4)P 2 and 5-phosphatase action in regulating cellular polarity comes from studies of neuronal polarization in Caenorhabditis elegans, in which aberrant polarization was caused by mutation of PI3K/age-1 or PTEN/daf-18 or the selective PtdIns(3,4)P 2 -binding target lamellipodin/MIG10 (Adler et al., 2006) . This suggests that in some polarized cell responses, the regulated role of PTEN may simply be to allow the re-direction of PtdInsP 3 metabolism via 5-phosphatase action to PtdIns(3,4)P 2 , presumably through suppression of PTEN 3-phosphatase activity.
Conclusions
Data now show that PTEN tumour suppressor activity can act in a dose-dependent, haploinsufficient manner in well-studied mouse models of prostate cancer and probably in other tumour types. This strengthens the need to understand the cellular mechanisms by which PTEN expression and activity are controlled. Here, we clearly still have much to learn, especially with novel data suggesting the existence of complex regulatory mechanism involving mono-and polyubiquitination, additional phosphorylation sites, mechanisms of redox regulation and even PTEN acetylation (Okumura et al., 2006; Covey et al., 2007; Trotman et al., 2007; Guo et al., 2008) .
